紫杉醇、奈达铂联合化疗治疗晚期子宫内膜癌临床观察
黄永惠;王运飞
【期刊名称】《医药前沿》 【年(卷),期】2013(000)011
【摘要】 目的观察紫杉醇与奈达铂联合化疗治疗晚期子宫内膜癌的疗效和毒副反应。方法32例晚期子宫内膜癌初治患者，17例接受紫杉醇+奈达铂（TP组）方案，同期接受 CAP（环磷酰胺+阿霉素+顺铂）方案(CAP 组)15例进行比较。结论紫杉醇联合奈达铂治疗晚期子宫内膜癌依从性好,毒副反应可以耐受。%Objective To evaluate the results of combined chemotherapy with paclitaxel plus nedaplatin in the treatment of advanced endometrial cancer. Result The TP group response rate was 41.2%, The other group was 40.0%. There was no significant difference between the two groups (P > 0.05). Conclusion Paclitaxel combined with nedaplatin in the treatmentof advanced endometrial cancer has good patient compliance, and the toxicities can be tolerated. 【总页数】1页(146-146)
【关键词】紫杉醇;奈达铂;子宫内膜癌 【作者】黄永惠;王运飞
【作者单位】隆昌人民医院肿瘤科 四川内江 642150;隆昌人民医院肿瘤科 四川内江 642150 【正文语种】中文 【中图分类】R730.5
紫杉醇、奈达铂联合化疗治疗晚期子宫内膜癌临床观察
